A prospective study comparing the effects of intramyometrial and continuous intravenous injection of oxytocin to maintain uterine contractions in the prevention of postpartum hemorrhage by cesarean section

aruse Satoshi0 个研究点目标入组 24 人开始时间: 2022年3月2日最近更新: 2024年4月23日

试验速览

暂无简介。

•1. Preoperative ASA-PS (ASA physical status) 2
•2. Singleton
•3. 37 weeks or more gestation
•4.Patients scheduled for elective cesarean section with spinal stem anesthesia
•5.Those who are between 20 and 40 years old at the time of obtaining consent.
•6.Those who have given their consent for this study by signing the consent form.

•1. Obvious obstetric diseases (uterine fibroids, uterine adenomyosis, endometriotic cysts, giant baby, excessive amniotic fluid, gestational hypertension), cardiac diseases
•2. Patients with obvious obstetrical diseases (uterine fibroids, endometrial cysts, giant babies, excessive amniotic fluid, gestational hypertension), cardiac diseases, blood coagulation abnormalities, and spinal diseases that would make it difficult to perform spinal stem anesthesia
•Those who are in labor.
•3. Those whose water has broken.
•4.Those with abnormal placental position
•5. Those with other placental abnormalities
•6. Those with multiple pregnancies
•7.Those with uterine malformation
•8.Those with oxytocin allergy
•9. Obesity (BMI above 30 at 35-36 weeks gestation)
•10. Those who have had 3 or more deliveries
•11.Those who have a history of postpartum hemorrhage.
•12.Those who are judged by the principal investigator or sub-investigator to be inappropriate for inclusion in this study.

发起方

aruse Satoshi